# Outcomes of the Use of Sodium Bicarbonate (8.4%) Solution as a Catheter Lock Solution to Prevent Hemodialysis Catheter Loss Due to Lumen Clot Formation

> **NCT03627884** · PHASE4 · COMPLETED · sponsor: **Coney Island Hospital, Brooklyn, NY** · enrollment: 451 (actual)

## Conditions studied

- End Stage Renal Disease
- Acute Renal Failure
- Hemodialysis Catheter Infection
- Hemodialysis Complication
- Hemodialysis Access Failure
- Hemodialysis Catheter-Associated Bacteremia

## Interventions

- **DRUG:** Sodium Bicarbonate Catheter Lock Solution
- **DRUG:** Normal Saline Catheter Lock Solution

## Key facts

- **NCT ID:** NCT03627884
- **Lead sponsor:** Coney Island Hospital, Brooklyn, NY
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-01
- **Primary completion:** 2018-03-30
- **Final completion:** 2018-03-30
- **Target enrollment:** 451 (ACTUAL)
- **Last updated:** 2018-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03627884

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03627884, "Outcomes of the Use of Sodium Bicarbonate (8.4%) Solution as a Catheter Lock Solution to Prevent Hemodialysis Catheter Loss Due to Lumen Clot Formation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03627884. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*